Skip to main content

Table 3 Cost reductions for avoided complications for the Spanish type 2 diabetes population with starting HbA1c > 48 mmol/mol

From: Improving management of glycaemic control in people with T2DM in primary care: estimation of the impact on the clinical complications and associated costs

Adult type 2 diabetes per-person cost reductions

 

5 years

10 years

15 years

20 years

25 years

> 48 to ≤58 mmol/mol

€198

€1754

€3653

€5221

€6027

58 to ≤64 mmol/mol

€548

€2492

€4563

€6108

€6633

64 to ≤75 mmol/mol

€1569

€4249

€6892

€9039

€10,233

> 75 mmol/mol

€1588

€4529

€7647

€10,369

€11,966

Adult type 2 diabetes total population cost reductions

 

5 years

10 years

15 years

20 years

25 years

> 48 to ≤58 mmol/mol

€200,133,593

€1,772,900,617

€3,692,363,715

€5,277,260,048

€6,091,945,280

58 to ≤64 mmol/mol

€160,234,152

€728,656,033

€1,334,212,472

€1,785,967,517

€1,939,476,513

64 to ≤75 mmol/mol

€499,489,460

€1,352,664,574

€2,194,060,778

€2,877,555,916

€3,257,664,530

> 75 mmol/mol

€458,695,151

€1,308,205,503

€2,208,842,455

€2,995,094,470

€3,456,389,279

TOTAL

€1.319 bn

€5.162 bn

€9.429 bn

€12.936 bn

€14.745 bn